Drug Absorption

2
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

AS
AB ScienceFrance - Paris
2 programs
2
Berberine incorporated in gamma cyclodextrinPhase 11 trial
HRG80™ Red GinsengPhase 11 trial
Active Trials
NCT04918667Not Yet RecruitingEst. Dec 2026
NCT04932265SuspendedEst. Dec 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AB ScienceBerberine incorporated in gamma cyclodextrin
AB ScienceHRG80™ Red Ginseng

Clinical Trials (2)

NCT04918667AB ScienceBerberine incorporated in gamma cyclodextrin

Effect of Gamma-cyclodextrin on the Bioavailability of Berberine

Start: Sep 2024Est. completion: Dec 2026
Phase 1Not Yet Recruiting
NCT04932265AB ScienceHRG80™ Red Ginseng

Effect of Gamma-cyclodextrin on the Bioavailability of Ginsenosides

Start: Sep 2021Est. completion: Dec 2025
Phase 1Suspended

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space